Literature DB >> 29094445

Kidney transplantation in a child with Pierson syndrome.

Sanem Guler1, Sertac Cimen1, Phillip Acott2, Kathy Whelan3, Michele Molinari1.   

Abstract

Congenital nephrotic syndrome is commonly associated with mutations in genes that encode podocyte and slit diaphragm proteins or the structural and regulatory proteins of the GBM. These mutations lead to the formation of dysfunctional proteins, which account for the resistance of the renal manifestations to conventional treatment methods. Consequently, patients become renal replacement therapy dependent. Mutation of the LAMB2 gene is associated with Pierson syndrome, which is an autosomal recessive disorder characterized by congenital nephrotic syndrome and ocular abnormalities. In this report, a 2-year-old male patient who was diagnosed with Pierson syndrome is presented. He had bilateral microcoria and developmental delay in addition to nephrotic syndrome. His renal function deteriorated rapidly, and he underwent a deceased donor kidney transplantation. He showed dramatic improvement after kidney transplantation; in addition to having good renal function, he started to catch up to his peers in terms of growth. Pierson syndrome should be considered during the diagnostic investigations of children with renal manifestations and ocular abnormalities. Children with Pierson syndrome must be evaluated in terms of kidney transplantation as soon as they are diagnosed.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Pierson syndrome; congenital nephrotic syndrome; kidney transplantation; microcoria

Mesh:

Year:  2017        PMID: 29094445     DOI: 10.1111/petr.13076

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  1 in total

1.  Gastrointestinal symptoms as an extended clinical feature of Pierson syndrome: a case report and review of the literature.

Authors:  Kei Nishiyama; Mari Kurokawa; Michiko Torio; Yasunari Sakai; Mitsuru Arima; Shoko Tsukamoto; Satoshi Obata; Shogo Minamikawa; Kandai Nozu; Noriyuki Kaku; Yoshihiko Maehara; Koh-Hei Sonoda; Tomoaki Taguchi; Shouichi Ohga
Journal:  BMC Med Genet       Date:  2020-04-15       Impact factor: 2.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.